Serologic follow-up of children born to mothers with Ro/SSA autoantibodies

Lupus

Volumn 18, Issue 9, 2009, Pages 792-798

  Klauninger, R ^a   Skog, A ^a   Horvath, L ^a   Winqvist, O ^a   Edner, A ^a   Bremme, K ^a   Sonesson, S E ^a   Wahren Herlenius, M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Congenital heart block; Neonatal lupus; Ro52; SSA

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LA ANTIBODY; RECOMBINANT ANTIGEN; RO ANTIBODY; SYNTHETIC PEPTIDE;

ANTIBODY BLOOD LEVEL; ARTICLE; ATRIOVENTRICULAR BLOCK; BREAST FEEDING; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; LUPUS ERYTHEMATOSUS; MATERNAL BLOOD; MOTHER CHILD RELATION; NEWBORN LUPUS ERYTHEMATOSUS; PLACENTAL TRANSFER; PRIORITY JOURNAL; SEROLOGY; SKIN DEFECT;

AUTOANTIBODIES; AUTOANTIGENS; BREAST FEEDING; COHORT STUDIES; FEMALE; FETUS; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, CUTANEOUS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RIBONUCLEOPROTEINS;

EID: 67650606763     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309103188     Document Type: Article

References (29)

1. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983; 309: 209-212.
2. Buyon JP, Clancy RM. Neonatal lupus: Basic research and clinical perspectives. Rheum Dis Clin North Am 2005; 31: 299-313.
3. Wahren-Herlenius M, Sonesson SE. Specificity and effector mechanisms of autoantibodies in congenital heart block. Curr Opin Immunol 2006; 18: 690-696.
4. Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658-1666.
5. Sonesson SE, Salomonsson S, Jacobson L-A, Bremme K, Wahren-Herlenius M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro52-kd antibodies. Arthritis Rheum 2004; 50: 1253-1261.
6. Litsey SE, Noonan JA, OConnor WN, Cottrill CM, Mitchell B. Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med 1985; 312: 98-100.
7. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/ fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004; 50: 173-182.
8. Buyon JP, Winchester RJ, Slade SG, et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993; 36: 1263-1273.
9. Julkunen H, Kurki P, Kaaja R, et al. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993; 36: 1588-1598.
10. Dörner T, Chaoui R, Feit E, Goldner B, Yamamoto K, Hiepe F. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block. J Autoimmun 1995; 8: 675-684.
11. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002; 46: 1233-1241.
12. Fritsch C, Hoebeke J, Dali H, et al. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block. Arthritis Res Ther 2006; 8: R4.
13. Salomonsson S, Sonesson SE, Ottosson L, et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005; 201: 11-17.
14. Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-1835.
15. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: A multicenter experience. J Am Coll Cardiol 1991; 17: 1360-1366.
16. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120: 544-551.
17. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
19. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
20. Andelfinger G, Fouron JC, Sonesson SE, Proulx F. Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques. Am J Cardiol 2001; 88: 1433-1436.
21. Skog A, Wahren-Herlenius M, Bremme K, Sonesson S-E. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/ SSA autoantibodies. Pediatrics 2008; 121: E803-e809.
22. Elagib KEE, Tengnér P, Levi M, et al. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjögren's syndrome. Arthritis Rheum 1999; 42: 2471-2478.
23. Ottosson L, Salomonsson S, Hennig J, et al. Structurally derived mutations define congenital heart block related epitopes within the 200-239 amino acid stretch of the Ro52 protein. Scand J Immunol 2005; 61: 109-118.
24. Strandberg L, Winqvist O, Sonesson S-E, et al. Antibodies to amino acid 200-239 (p200) of Ro52 as serologic markers for the risk of developing congenital heart block. Clin Exp Immunol 2008; 154: 30-37.
25. Wahren M, Ringertz NR, Pettersson I. IgM and IgG subclass distribution of human anti-Ro/SSA 60 kDa autoantibodies. Scand J Immunol 1994; 39: 179-183.
26. Tengnér P, Halse A-K, Haga H-J, Jonsson R, Wahren-Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands frompatients with Sjögren's syndrome. Arthritis Rheum 1998; 41: 2238-2248.
27. Strandberg L, Salomonsson S, Bremme K, Sonesson SE, Wahren-Herlenius M. Ro52, Ro60 and La autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block pregnancies. Lupus 2006; 15: 346-353.
28. Askanase AD, Miranda-Carus ME, Tang X, Katholi M, Buyon JP. The presence of IgG antibodies reactive with components of the SSA/Ro- SSB/La complex in human breast milk: Implications in neonatal lupus. Arthritis Rheum 2002; 46: 269-271.
29. Cimaz R, Meroni PL, Brucato A, et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum. 2003; 48: 266-268.